abstract |
The invention relates to novel compounds of the formula (I), wherein R is (a) or (b), X is O or S and R?1, R2, R3, R4, R5, R6, R7, R8¿ and n have the meaning given in claim 1. It also relates to the salts of said compounds. Said compounds and salts demonstrate endothelin receptor antagonistic properties. |